5-(2-Nitrophenyl)-1,3,4-thiadiazol-2-amine, 1g

N-6-Benzyladenine, 95.0%, 1g

3-Benzyl-7-chloro-3H-[1,2,3]-triazolo[4,5-d]pyrimidine, 95.0%, 1g

2-(3-Bromophenyl)-1,1,1-trifluoropropan-2-ol, 95%, 500mg

3-(1-methyl-1H-pyrazol-4-yl)propan-1-ol, 95.0%, 1g

tert-Butyl (R)-(1-cyclopropyl-2-hydroxyethyl)carbamate, 97%, 2.5g

3-Chloro-1-ethyl-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile, 97%, 1g

Piperidine-1,4-dicarboxylic acid 1-benzyl ester 4-methyl ester, 95.0%, 10g

Ethyl 4-((4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylate, 95.0%, 250mg

1,3-Diiodobenzene>99.0%(GC)5g

4-Ethyl-5-m-tolyloxymethyl-4H-[1,2,4]triazole-3-thiol, 95.0%, 1g

3-(4-Hydroxy-3,5-dimethoxyphenyl)propanoic acid, 97+%, 5g

Planspannungsfreies PLPOLi 100x/1,25 Ölimmersions-IOS-Objektiv für iScope-Transmissionspolarisation, 0,17 mm Deckglaskorrektur. Arbeitsabstand 0,13 mm